Efficacité et tolérance du tocilizumab chez les patients atteints de PR : données du registre marocain des biothérapies (RBSMR)
S. Bouayad, R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), L. Ichchou(Hôpital El Ayachi), L. Achemlal, I. Ghozlani(Régie Autonome Multi Services D'Agadir), Bouchra Amine(Hôpital El Ayachi), Y Boujenane(Mohammed V University), H. Hassikou, F. Allali(Délégation Paris 5), Lamia Oulkadi(Centre Hospitalier Ibn Sina), I. El Bouchti, Meryem Eddaoudi(Hôpital El Ayachi), R. Bensabah(Hôpital El Ayachi), Taoufik Harzy(Hôpital El Ayachi), I. Elbinoune(Centre Hospitalier Ibn Sina), Rédouane Abouqal(Mohammed V University), Ihsane Hmamouchi(International University of Rabat), S. Rostom(Mohammed V University), O. Mkinsi(Centre Hospitalier Universitaire Ibn Rochd), A. Souissi(Hôpital El Ayachi), A. El Maghraoui
Cited by 0
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114